203 related articles for article (PubMed ID: 32779523)
1. Computational studies on bacterial secondary metabolites against breast cancer.
Ravnik Z; Muthiah I; Dhanaraj P
J Biomol Struct Dyn; 2021 Nov; 39(18):7056-7064. PubMed ID: 32779523
[TBL] [Abstract][Full Text] [Related]
2. Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.
Mikó E; Kovács T; Sebő É; Tóth J; Csonka T; Ujlaki G; Sipos A; Szabó J; Méhes G; Bai P
Cells; 2019 Mar; 8(4):. PubMed ID: 30934972
[TBL] [Abstract][Full Text] [Related]
3. The microbiome and breast cancer: a review.
Chen J; Douglass J; Prasath V; Neace M; Atrchian S; Manjili MH; Shokouhi S; Habibi M
Breast Cancer Res Treat; 2019 Dec; 178(3):493-496. PubMed ID: 31456069
[TBL] [Abstract][Full Text] [Related]
4. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer.
Parida S; Sharma D
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):392-405. PubMed ID: 30981803
[TBL] [Abstract][Full Text] [Related]
5. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
6. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
Rao Malla R; Marni R; Kumari S; Chakraborty A; Lalitha P
Clin Breast Cancer; 2022 Apr; 22(3):200-211. PubMed ID: 34625387
[TBL] [Abstract][Full Text] [Related]
7. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis.
Spatz M; Ciocan D; Merlen G; Rainteau D; Humbert L; Gomes-Rochette N; Hugot C; Trainel N; Mercier-Nomé F; Domenichini S; Puchois V; Wrzosek L; Ferrere G; Tordjmann T; Perlemuter G; Cassard AM
JHEP Rep; 2021 Apr; 3(2):100230. PubMed ID: 33665587
[TBL] [Abstract][Full Text] [Related]
8. An unexpected link: The role of mammary and gut microbiota on breast cancer development and management (Review).
Toumazi D; El Daccache S; Constantinou C
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786630
[TBL] [Abstract][Full Text] [Related]
9. Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy.
Jaye K; Chang D; Li CG; Bhuyan DJ
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012771
[TBL] [Abstract][Full Text] [Related]
10. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling.
Sipos A; Ujlaki G; Mikó E; Maka E; Szabó J; Uray K; Krasznai Z; Bai P
Mol Med; 2021 Apr; 27(1):33. PubMed ID: 33794773
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Diseases and Gut Microbiota.
Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
Singh D; Khan MA; Siddique HR
Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
[TBL] [Abstract][Full Text] [Related]
13. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
[TBL] [Abstract][Full Text] [Related]
15. Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights.
Parida S; Sharma D
Cells; 2020 Apr; 9(5):. PubMed ID: 32354130
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis of human microbiome and infectious diseases.
Gupta A; Singh V; Mani I
Prog Mol Biol Transl Sci; 2022; 192(1):33-51. PubMed ID: 36280324
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications.
Chen J; Vitetta L
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717871
[TBL] [Abstract][Full Text] [Related]
18. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study.
Plaza-Díaz J; Álvarez-Mercado AI; Ruiz-Marín CM; Reina-Pérez I; Pérez-Alonso AJ; Sánchez-Andujar MB; Torné P; Gallart-Aragón T; Sánchez-Barrón MT; Reyes Lartategui S; García F; Chueca N; Moreno-Delgado A; Torres-Martínez K; Sáez-Lara MJ; Robles-Sánchez C; Fernández MF; Fontana L
BMC Cancer; 2019 May; 19(1):495. PubMed ID: 31126257
[TBL] [Abstract][Full Text] [Related]
19. The Role of Succinate in the Regulation of Intestinal Inflammation.
Connors J; Dawe N; Van Limbergen J
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30583500
[TBL] [Abstract][Full Text] [Related]
20. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
